Regulatable lentiviral hematopoietic stem cell gene therapy in a mouse model of Parkinson's disease

Neuroscience

• Glial Cell Line-Derived Neurotrophic Factor 100%
• Tetrahydropyridine 50%
• Doxycycline 50%
• Neurotrophic Factor Expression 33%
• Parkinson's Disease 25%
• Neuroprotective Agent 16%
• Gene Expression 16%
• Dopamine 8%
• Tyrosine Hydroxylase 8%
• Neuroprotection 8%
• Hematopoietic Stem Cell 8%
• Midbrain 8%
• Lentivirus Vector 8%
• Suppression 8%

Biochemistry, Genetics and Molecular Biology

• Glial Cell Line-Derived Neurotrophic Factor 66%
• Gene Expression 16%
• Mouse Model 16%
• Motor Activity 16%
• C57BL 6 Mouse 8%
• Gene Therapy 8%
• Hematopoietic Stem Cell 8%
• Animal 8%
• Tyrosine Hydroxylase 8%
• Dopamine 8%
• Hematopoietic Stem Cell Transplantation 8%
• Syngenic 8%
• Lentivirus Vector 8%
• Bone 8%
• Regulatory Mechanism 8%
• Clinical Trial 8%